The survival analysis of PCMT1 in breast cancer showed that the high expression of PCMT1 can lead to shorter OS, RFS, and PPS in breast cancer patients, suggesting that high expression of PCMT1 is significantly related to the poor prognosis of breast cancer. Here, PCMT1 is linked to breast carcinoma.